naltrexone and Gambling

naltrexone has been researched along with Gambling in 33 studies

Research

Studies (33)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (6.06)18.2507
2000's16 (48.48)29.6817
2010's12 (36.36)24.3611
2020's3 (9.09)2.80

Authors

AuthorsStudies
Bowden-Jones, H; Cowlishaw, S; Dowling, N; Lubman, D; Merkouris, S; Thomas, S1
Etuk, R; Kraus, SW; Potenza, MN1
Bäckström, P; Kiianmaa, K; Oinio, V; Piepponen, P; Raasmaja, A; Sundström, M; Uhari-Väänänen, J1
Lee, JC; Takayesu, AG1
Benyamina, A; Hamzaoui, S; Kebir, O; Laqueille, X; Leite, C; Mouaffak, F1
Bowden-Jones, H; Smith, N; Ward, S1
Kim, SW; Yoon, G1
Bartley, CA; Bloch, MH1
Alho, H; Basnet, S; Castrén, S; Kovanen, L; Lahti, T; Pankakoski, M; Partonen, T; Saarikoski, ST1
Fontenelle, LF; Piquet-Pessôa, M1
Dowling, NA; Lorains, FK; Merkouris, SS1
Di Ciano, P; Le Foll, B1
Allen, AR; Balleine, B; Carter, A; Clark, L; Dowling, NA; Gainsbury, SM; Goudriaan, AE; Grant, J; Hall, W; Hayes, A; Hodgins, D; Lattimore, R; Livingstone, C; Lorenzetti, V; Lubman, D; Murawski, C; Parkes, L; Petry, N; Room, R; Singh, B; Thomas, A; Townshend, P; van Holst, R; Youssef, G; Yücel, M1
Grant, JE; Hollander, E; Kim, SW; Potenza, MN1
Blanco, C; Grant, JE; Hollander, E; Kim, SW; Potenza, MN1
Grant, JE; Hollander, E; Kim, SW; Odlaug, BL; Potenza, MN1
Bowden-Jones, H; George, S1
Grant, JE; Grosz, RL; Kim, SW1
Ladoceur, R; Toneatto, T1
Grant, JE; Grosz, R1
Baker, B; Baldini-Rossi, N; Hollander, E; Pallanti, S; Sood, E1
Dannon, PN; Gonopolski, Y; Kotler, M; Lowengrub, K; Musin, E1
Nestler, EJ; Tamminga, CA1
Cunningham-Williams, R; Grant, JE; Hollander, E; Kallio, A; Nurminen, T; Potenza, MN; Smits, G1
Arnestad, HM; Holsten, F; Iversen, E; Kvale, G; Laberg, JC; Molde, H; Pallesen, S; Skutle, A; Støylen, IJ1
Dannon, PN; Gonopolsky, Y; Kotler, M; Lowengrub, K; Musin, E1
Grant, JE; Hartman, BK; Kim, SW1
Crockford, DN; el-Guebaly, N1
Kim, SW1
Buchalter, AJ; DeCaria, CM; Hollander, E1
Adson, DE; Grant, JE; Kim, SW; Shin, YC1
Grant, JE; Kim, SW2

Reviews

11 review(s) available for naltrexone and Gambling

ArticleYear
Pharmacological interventions for the treatment of disordered and problem gambling.
    The Cochrane database of systematic reviews, 2022, 09-22, Volume: 9

    Topics: Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Gambling; Headache; Humans; Naltrexone; Narcotic Antagonists; Nausea; Olanzapine

2022
Current pharmacotherapy for gambling disorder: a systematic review.
    Expert opinion on pharmacotherapy, 2020, Volume: 21, Issue:3

    Topics: Behavior, Addictive; Diagnosis, Dual (Psychiatry); Gambling; Humans; Naltrexone; Narcotic Antagonists; Psychotherapy; Randomized Controlled Trials as Topic; Substance-Related Disorders

2020
Naltrexone in the Treatment of Broadly Defined Behavioral Addictions: A Review and Meta-Analysis of Randomized Controlled Trials.
    European addiction research, 2017, Volume: 23, Issue:4

    Topics: Behavior, Addictive; Gambling; Humans; Naltrexone; Narcotic Antagonists; Randomized Controlled Trials as Topic

2017
Meta-analysis: pharmacological treatment of pathological gambling.
    Expert review of neurotherapeutics, 2013, Volume: 13, Issue:8

    Topics: Antipsychotic Agents; Gambling; Humans; Naltrexone; Narcotic Antagonists; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors

2013
Opioid antagonists in broadly defined behavioral addictions: a narrative review.
    Expert opinion on pharmacotherapy, 2016, Volume: 17, Issue:6

    Topics: Alcoholism; Bulimia; Compulsive Behavior; Disruptive, Impulse Control, and Conduct Disorders; Gambling; Humans; Naltrexone; Narcotic Antagonists; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Trichotillomania

2016
Interventions for comorbid problem gambling and psychiatric disorders: Advancing a developing field of research.
    Addictive behaviors, 2016, Volume: 58

    Topics: Acetylcysteine; Antimanic Agents; Antipsychotic Agents; Anxiety Disorders; Behavior Therapy; Bipolar Disorder; Citalopram; Cognitive Behavioral Therapy; Comorbidity; Free Radical Scavengers; Gambling; Humans; Lithium Compounds; Mental Disorders; Motivational Interviewing; Naltrexone; Narcotic Antagonists; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Tobacco Use Disorder

2016
Neuroscience in gambling policy and treatment: an interdisciplinary perspective.
    The lancet. Psychiatry, 2017, Volume: 4, Issue:6

    Topics: Administrative Personnel; Appetite Depressants; Decision Making; Diagnostic and Statistical Manual of Mental Disorders; Disruptive, Impulse Control, and Conduct Disorders; Gambling; Harm Reduction; Humans; Naloxone; Naltrexone; Narcotic Antagonists; Neurosciences; Public Health

2017
Treatment of pathological gambling: a critical review of the literature.
    Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors, 2003, Volume: 17, Issue:4

    Topics: Behavior, Addictive; Cognitive Behavioral Therapy; Fluvoxamine; Gambling; Guidelines as Topic; Humans; Naltrexone; Narcotic Antagonists; Selective Serotonin Reuptake Inhibitors; Self-Help Groups

2003
Pharmacological treatments of pathological gambling.
    Journal of gambling studies, 2005,Spring, Volume: 21, Issue:1

    Topics: Antidepressive Agents, Second-Generation; Behavior, Addictive; Bupropion; Comorbidity; Disruptive, Impulse Control, and Conduct Disorders; Dose-Response Relationship, Drug; Fluvoxamine; Gambling; Humans; Naltrexone; Outcome Assessment, Health Care; Paroxetine; Piperazines; Research Design; Selective Serotonin Reuptake Inhibitors; Substance-Related Disorders; Triazoles

2005
Outcome of pharmacological treatments of pathological gambling: a review and meta-analysis.
    Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:4

    Topics: Antidepressive Agents; Antimanic Agents; Gambling; Humans; Models, Statistical; Naltrexone; Narcotic Antagonists; Psychiatric Status Rating Scales; Psychotropic Drugs; Regression Analysis

2007
Pathological gambling.
    The Psychiatric clinics of North America, 2000, Volume: 23, Issue:3

    Topics: Cognitive Behavioral Therapy; Comorbidity; Diagnosis, Differential; Disruptive, Impulse Control, and Conduct Disorders; Female; Gambling; Humans; Male; Mental Disorders; Naltrexone; Narcotic Antagonists; Residential Treatment; Selective Serotonin Reuptake Inhibitors; Self-Help Groups

2000

Trials

8 trial(s) available for naltrexone and Gambling

ArticleYear
A Randomised, Double-Blind, Placebo-Controlled Trial of As-Needed Naltrexone in the Treatment of Pathological Gambling.
    European addiction research, 2016, Volume: 22, Issue:2

    Topics: Adult; Aged; Combined Modality Therapy; Double-Blind Method; Female; Gambling; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Polymorphism, Single Nucleotide; Psychotherapy, Brief; Receptors, Opioid, mu; Treatment Outcome; Young Adult

2016
Predicting response to opiate antagonists and placebo in the treatment of pathological gambling.
    Psychopharmacology, 2008, Volume: 200, Issue:4

    Topics: Adult; Age Factors; Aged; Alcoholism; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gambling; Humans; Logistic Models; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Predictive Value of Tests; Psychometrics; Severity of Illness Index; Treatment Outcome; Young Adult

2008
The Gambling Symptom Assessment Scale (G-SAS): a reliability and validity study.
    Psychiatry research, 2009, Mar-31, Volume: 166, Issue:1

    Topics: Disruptive, Impulse Control, and Conduct Disorders; Follow-Up Studies; Gambling; Humans; Naltrexone; Narcotic Antagonists; Obsessive-Compulsive Disorder; Personality Inventory; Psychometrics; Reproducibility of Results

2009
Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study.
    The British journal of psychiatry : the journal of mental science, 2010, Volume: 197, Issue:4

    Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gambling; Humans; Intention to Treat Analysis; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Placebos; Treatment Outcome; United States; Young Adult

2010
Sustained-release bupropion versus naltrexone in the treatment of pathological gambling: a preliminary blind-rater study.
    Journal of clinical psychopharmacology, 2005, Volume: 25, Issue:6

    Topics: Adult; Bupropion; Cohort Studies; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Gambling; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Pilot Projects; Single-Blind Method; Socioeconomic Factors; Treatment Outcome

2005
Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling.
    The American journal of psychiatry, 2006, Volume: 163, Issue:2

    Topics: Adult; Age of Onset; Ambulatory Care; Behavior, Addictive; Disruptive, Impulse Control, and Conduct Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drugs, Investigational; Female; Gambling; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Obsessive-Compulsive Disorder; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome

2006
A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges.
    The Journal of clinical psychiatry, 2008, Volume: 69, Issue:5

    Topics: Adolescent; Adult; Aged; Diagnostic and Statistical Manual of Mental Disorders; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Drug Administration Schedule; Female; Gambling; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists

2008
Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling.
    Biological psychiatry, 2001, Jun-01, Volume: 49, Issue:11

    Topics: Adolescent; Adult; Aged; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Gambling; Humans; Interview, Psychological; Liver Function Tests; Middle Aged; Naltrexone; Narcotic Antagonists; Single-Blind Method; Surveys and Questionnaires

2001

Other Studies

14 other study(ies) available for naltrexone and Gambling

ArticleYear
The role of opioidergic system in modulating cost/benefit decision-making in alcohol-preferring AA rats and Wistar rats.
    Behavioural pharmacology, 2021, 04-01, Volume: 32, Issue:2&3

    Topics: Alcohol Drinking; Analgesics, Opioid; Animals; Behavior, Animal; Cost-Benefit Analysis; Decision Making; Gambling; Male; Morphine; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar; Reward; Sucrose

2021
Gambling Disorder and Concurrent Alcohol Use Disorder Treated With Naltrexone.
    The primary care companion for CNS disorders, 2017, Jul-20, Volume: 19, Issue:4

    Topics: Adult; Alcoholism; Depressive Disorder; Gambling; Humans; Male; Naltrexone; Narcotic Antagonists

2017
The use of naltrexone in pathological and problem gambling: A UK case series.
    Journal of behavioral addictions, 2018, Sep-01, Volume: 7, Issue:3

    Topics: Adult; Craving; Female; Follow-Up Studies; Gambling; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Problem Behavior; Recurrence; Retrospective Studies; Severity of Illness Index; Treatment Outcome; United Kingdom

2018
Monthly injectable naltrexone for pathological gambling.
    The American journal of psychiatry, 2013, Volume: 170, Issue:6

    Topics: Drug Administration Schedule; Gambling; Humans; Injections, Intramuscular; Male; Medication Adherence; Middle Aged; Naltrexone

2013
Evaluating the Impact of Naltrexone on the Rat Gambling Task to Test Its Predictive Validity for Gambling Disorder.
    PloS one, 2016, Volume: 11, Issue:5

    Topics: Analysis of Variance; Animals; Behavior, Animal; Choice Behavior; Decision Making; Disease Models, Animal; Gambling; Male; Naltrexone; Narcotic Antagonists; Rats

2016
Gambling addiction.
    BMJ (Clinical research ed.), 2011, Dec-30, Volume: 343

    Topics: Adult; Antimanic Agents; Behavior Control; Behavior, Addictive; Gambling; Humans; Male; Naltrexone; Narcotic Antagonists; Psychological Techniques; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Self-Help Groups; Treatment Outcome

2011
Pathological gambling. Current status and new treatments.
    Minnesota medicine, 2002, Volume: 85, Issue:7

    Topics: Behavior, Addictive; Dose-Response Relationship, Drug; Drug Administration Schedule; Gambling; Humans; Naltrexone; Narcotic Antagonists; Selective Serotonin Reuptake Inhibitors

2002
Pharmacotherapy outcome in older pathological gamblers: a preliminary investigation.
    Journal of geriatric psychiatry and neurology, 2004, Volume: 17, Issue:1

    Topics: Aged; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Comorbidity; Depressive Disorder, Major; Disruptive, Impulse Control, and Conduct Disorders; Drug Therapy, Combination; Female; Follow-Up Studies; Gambling; Humans; Male; Middle Aged; Naltrexone; Personality Assessment; Phobic Disorders; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

2004
Pathological gambling: focusing on the addiction, not the activity.
    The American journal of psychiatry, 2006, Volume: 163, Issue:2

    Topics: Behavior, Addictive; Gambling; Humans; Naltrexone; Narcotic Antagonists; Nucleus Accumbens; Receptors, Opioid; Substance-Related Disorders; Treatment Outcome

2006
12-month follow-up study of drug treatment in pathological gamblers: a primary outcome study.
    Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:6

    Topics: Adolescent; Adult; Analysis of Variance; Bupropion; Delayed-Action Preparations; Drug Therapy; Fluvoxamine; Follow-Up Studies; Fructose; Gambling; Humans; Israel; Male; Middle Aged; Naltrexone; Outcome Assessment, Health Care; Psychiatric Status Rating Scales; Psychopharmacology; Recurrence; Reproducibility of Results; Surveys and Questionnaires; Time Factors; Topiramate

2007
Naltrexone in the treatment of pathological gambling and alcohol dependence.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1998, Volume: 43, Issue:1

    Topics: Alcoholism; Combined Modality Therapy; Comorbidity; Gambling; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists

1998
Opioid antagonists in the treatment of impulse-control disorders.
    The Journal of clinical psychiatry, 1998, Volume: 59, Issue:4

    Topics: Adult; Compulsive Behavior; Disruptive, Impulse Control, and Conduct Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gambling; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists

1998
An open naltrexone treatment study in pathological gambling disorder.
    International clinical psychopharmacology, 2001, Volume: 16, Issue:5

    Topics: Adolescent; Adult; Aged; Disruptive, Impulse Control, and Conduct Disorders; Dose-Response Relationship, Drug; Female; Gambling; Humans; Male; Middle Aged; Motivation; Naltrexone; Personality Assessment; Psychiatric Status Rating Scales; Treatment Outcome

2001
Demographic and clinical features of 131 adult pathological gamblers.
    The Journal of clinical psychiatry, 2001, Volume: 62, Issue:12

    Topics: Adult; Aged; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Female; Gambling; Humans; Male; Middle Aged; Motivation; Naltrexone; Paroxetine; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Socioeconomic Factors

2001